We are live on ! Find out more
TXG icon

10x Genomics
TXG

340 hedge funds and large institutions have $15.2B invested in 10x Genomics in 2021 Q2 according to their latest regulatory filings, with 67 funds opening new positions, 157 increasing their positions, 76 reducing their positions, and 46 closing their positions.

New
Increased
Maintained
Reduced
Closed

198% more call options, than puts

Call options by funds: $86.3M | Put options by funds: $29M

107% more repeat investments, than reductions

Existing positions increased: 157 | Existing positions reduced: 76

46% more first-time investments, than exits

New positions opened: 67 | Existing positions closed: 46

19% more capital invested

Capital invested by funds: $12.8B → $15.2B (+$2.45B)

7.15% more ownership

Funds ownership: 81.98% → 89.13% (+7.1%)

5% more funds holding

Funds holding: 323 → 340 (+17)

10% less funds holding in top 10

Funds holding in top 10: 10 → 9 (-1)

Holders
340
Holders Change
+17
Holders Change %
+5.26%
% of All Funds
5.92%
Holding in Top 10
9
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-10%
% of All Funds
0.16%
New
67
Increased
157
Reduced
76
Closed
46
Calls
$86.3M
Puts
$29M
Net Calls
+$57.4M
Net Calls Change
+$64.6M

Top Buyers

1
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$658M
2
BlackRock
BlackRock
New York
+$406M
3
AIM
ARK Investment Management
Florida
+$144M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$99.8M
5
BCM
Brown Capital Management
Maryland
+$99.6M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$334M
2
FCMI
Foresite Capital Management II
California
-$90.5M
3
N
Nuveen
North Carolina
-$71.3M
4
MCAV
Meritech Capital Associates V
California
-$59.6M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$58.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
RI
26
RTW Investments
New York
$144M +$4.16M +22,966 +3%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$143M -$12.1M -66,799 -8%
EVM
28
Eaton Vance Management
Massachusetts
$142M +$42.1M +232,488 +47%
American Century Companies
29
American Century Companies
Missouri
$141M +$7.05M +38,947 +6%
Norges Bank
30
Norges Bank
Norway
$130M +$41.6M +229,846 +53%
N
31
Nuveen
North Carolina
$128M -$71.3M -394,107 -38%
AllianceBernstein
32
AllianceBernstein
Tennessee
$128M +$4M +22,112 +3%
BAMCO Inc
33
BAMCO Inc
New York
$115M -$1.4M -7,709 -1%
Macquarie Group
34
Macquarie Group
Australia
$114M +$19.1M +105,609 +22%
Charles Schwab
35
Charles Schwab
California
$108M +$4.07M +22,515 +4%
JCM
36
JS Capital Management
New York
$106M +$4.22M +23,333 +5%
Goldman Sachs
37
Goldman Sachs
New York
$105M +$5.51M +30,436 +6%
UBS AM
38
UBS AM
Illinois
$101M +$3.66M +20,239 +4%
Northern Trust
39
Northern Trust
Illinois
$93.5M +$12.4M +68,786 +17%
Bank of America
40
Bank of America
North Carolina
$69.1M +$7.41M +40,969 +13%
Jennison Associates
41
Jennison Associates
New York
$64.5M -$14.6M -80,398 -20%
First Trust Advisors
42
First Trust Advisors
Illinois
$61.7M +$10.4M +57,735 +22%
Swiss National Bank
43
Swiss National Bank
Switzerland
$58.4M +$9.36M +51,724 +21%
Russell Investments Group
44
Russell Investments Group
United Kingdom
$55.4M +$4.45M +24,598 +10%
1832 Asset Management
45
1832 Asset Management
Ontario, Canada
$53M +$48.7M +269,000 New
Legal & General Group
46
Legal & General Group
United Kingdom
$51.4M +$14.3M +78,846 +43%
Mitsubishi UFJ Trust & Banking
47
Mitsubishi UFJ Trust & Banking
Japan
$49M +$38.5M +212,478 +563%
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$46.3M +$13.7M +75,798 +47%
BG
49
Bellevue Group
Switzerland
$45.6M +$657K +3,633 +2%
Fidelity International
50
Fidelity International
Bermuda
$39.7M -$10.2M -56,219 -22%
1
2
3 4 5

TXG Hedge Fund Activity: Q2 2021 in Review

340 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in 10x Genomics (TXG) for Q2 2021, worth a combined $15.2B — up 19% from $12.8B a quarter earlier.

Buyers outnumbered sellers: 67 funds opened new TXG positions and 46 closed out — a net gain of 21 holders — while 157 added to existing stakes and 76 trimmed.

The largest buyer was Baillie Gifford & Co, adding an estimated $658M. The largest seller was Fidelity Investments, cutting an estimated $334M.

  • 340 institutional investors held 10x Genomics (TXG) as of Q2 2021, up from 323 in Q1 2021.
  • Funds reported $15.2B of 10x Genomics stock for Q2 2021, up 19% quarter-over-quarter.
  • 67 funds opened new 10x Genomics positions in Q2 2021 and 46 closed out, a net change of +21 holders.
  • The largest 10x Genomics buyer in Q2 2021 was Baillie Gifford & Co, an estimated $658M added.
  • The largest 10x Genomics seller in Q2 2021 was Fidelity Investments, an estimated $334M sold.

Based on aggregated 13F filings for Q2 2021.